My new paper on the private-sector contribution to pharmaceutical science, coauthored with Joe DiMasi and Chris Milne (both of Tufts University), can be found
here (pdf) or
here (HTML). The attendant op-ed, from today's
Wall Street Journal, can be found
here. Comments welcome.
1 comment:
Well, Ben, it does open a legitimate question from the left---since some [many] of these innovations are a result of basic government research, later developed by Big Pharma, it's a partnership, eh?
So what's the public's cut? I mean, if an oil company drills on public land, the state gets a taste of the profits.
Post a Comment